Zimmer Biomet Holdings Inc. is a global leader in musculoskeletal healthcare, dedicated to alleviating pain and improving the quality of life for patients worldwide. The company's mission revolves around innovation in orthopedic and dental solutions, focusing on advanced technologies and surgical products. Zimmer Biomet's strategy emphasizes strategic partnerships, research and development, and a commitment to enhancing patient outcomes through comprehensive solutions. With a diverse portfolio of products and a strong presence in the global market, Zimmer Biomet operates with the goal of transforming the healthcare landscape and providing exceptional value to healthcare providers and patients alike.

ZIMMER BIOMET HOLDINGS INC

Zimmer Biomet is set to acquire Paragon 28, Inc. for approximately $1.1 billion, a strategic move aimed at strengthening its foothold in the foot and ankle treatment market. This acquisition taps into a lucrative $5 billion market and allows Zimmer Biomet to diversify its offerings beyond traditional orthopedics. Paragon 28...

Zimmer Biomet to Acquire Paragon 28 for $1.1 Billion, Strengthening Foot and Ankle Orthopedic Offerings